AstraZeneca has breached the UK pharma industry's code of practice with a claim on its website for asthma drug Symbicort, while Organon overstepped the mark in its promotion of contraceptive Nexplanon ...

Organon shares trade at a discount, but there are no strong drivers for business growth. I see a fair value of $7.79 per share, which is 12% more than the current price ($6.97 at the time of writing).

Organon’s latest valuation update nudges its fair value estimate down from $9.67 to $9.36 and edges the discount rate up from 10.20% to 10.25%, a small but telling shift that mirrors Wall Street’s ...

After stopping birth control, you start ovulating again and can become pregnant. Barrier methods of birth control do not affect ovulation, so you can get pregnant as soon as you stop using them.

Women across the country bonded online over their “Ozempic babies” – surprise pregnancies while taking GLP-1 medications like Ozempic and Mounjaro, despite being on birth control or having a history ...

Organon (OGN) has drawn investor attention after a recent move in its share price, with the stock closing at $8.13. Short ...

Researchers are finally trying to understand the complex causes of menstrual pain, or dysmenorrhea—and potential solutions.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

America's Accountant' Dan Geltrude shares leadership lessons from his dogs, reader response to his book and more.

Chart does not reflect overnight price.